SPDR S&P Biotech: Top holdings
| | Company name | % Net assets | | Dendreon Corporation | 4.60% | | Celgene Corporation | 4.26% | | Alexion Pharmaceuticals, Inc. | 4.23% | | Human Genome Sciences | 4.22% | | OSI Pharmaceuticals, Inc. | 4.07% | | Vertex Pharmaceuticals | 4.06% | | Cephalon, Inc. | 4.03% | | Acorda Therapeutics, Inc. | 4.02% | | Gilead Sciences, Inc. | 4.01% | | Amgen, Inc. | 3.98% | | Percentage of holdings 41.48% |
| Sector name | % Net assets |
|
Healthcare |
99.98% |
|
Industrial Materials |
0.00% |
|
Media |
0.00% |
|
Software |
0.00% |
|
Telecommunication |
0.00% |
|
Utilities |
0.00% |
|
Business Service |
0.00% |
|
Consumer Goods |
0.00% |
|
Consumer Service |
0.00% |
|
Energy |
0.00% |
| | Percentage of sectors 99.98% |
Holding data through 10/31/2009
Sector data through 10/31/2009
|
| |
Recent News